# Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders

> **NCT02118805** · — · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)
- Myasthenia Gravis
- Myopathies
- Stroke
- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02118805
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02118805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02118805, "Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02118805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*